April 4, 2018 / 8:29 PM / 3 months ago

BRIEF-Eleven Biotherapeutics Reports Q4 Loss Per Share $0.22

Reuters Staff

1 Min Read

April 4 (Reuters) - Eleven Biotherapeutics Inc:

* ELEVEN BIOTHERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 OPERATING RESULTS AND VICINIUM DEVELOPMENT PROGRESS

* ELEVEN BIOTHERAPEUTICS - NO REV WAS RECOGNIZED DURING QTR ENDED DEC. 31, 2017 VS $0.8 MLN FOR SAME THREE-MONTH PERIOD IN 2016

* ELEVEN BIOTHERAPEUTICS INC - EXPECTS TO HAVE CAPITAL TO FUND CURRENT OPERATING PLANS INTO Q1 2019

* ELEVEN BIOTHERAPEUTICS INC - CASH AND CASH EQUIVALENTS WERE $14.7 MILLION AS OF DECEMBER 31, 2017 Source text for Eikon: Further company coverage:

0 : 0